Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other ...

For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology.